4//SEC Filing
Dahms Bradford D. 4
Accession 0000899243-21-049427
CIK 0001745020other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 6:21 PM ET
Size
5.0 KB
Accession
0000899243-21-049427
Insider Transaction Report
Form 4
Dahms Bradford D.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-12-21$10.15/sh+1,970.036$20,000→ 1,970.036 total
Footnotes (1)
- [F1]The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $10.09 to $10.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Theseus Pharmaceuticals, Inc.
CIK 0001745020
Entity typeother
Related Parties
1- filerCIK 0001787307
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 6:21 PM ET
- Size
- 5.0 KB